Is the prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers an important factor for survival?: Experience of Institut Curie-Paris.

被引：0
|
作者：
Laki, F. [1 ]
Kirova, Y. M. [1 ]
Salmon, R. [1 ]
Asselain, B. [1 ]
Stoppa-Lyonnet, D. [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [31] Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers
    Madalinska, Joanna B.
    van Beurden, Marc
    Bleiker, Eveline M. A.
    Valdimarsdottir, Heiddis B.
    Lubsen-Brandsma, Lottie
    Massuger, Leon F.
    Mourits, Marian J. E.
    Gaarenstroom, Katja N.
    van Dorst, Eleonora B. L.
    van der Putten, Hans
    Boonstra, Henk
    Aaronson, Neil K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 301 - 307
  • [32] Barriers to hormone replacement therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers
    DiSilvestro, J. B.
    Haddad, J.
    Robison, K. M.
    Beffa, L. B.
    Laprise, J.
    Wilbur, J. Scalia
    Raker, C.
    Hofstatter, E.
    Dalela, D.
    Brown, A. K.
    Bradford, L.
    Toland, M.
    Stuckey, A. R.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 260 - 260
  • [33] Prophylactic Salpingo-Oophorectomy and Survival After BRCA1/2 Breast Cancer Resection
    Martelli, Gabriele
    Barretta, Francesco
    Vernieri, Claudio
    Folli, Secondo
    Pruneri, Giancarlo
    Segattini, Silvia
    Trapani, Anna
    Carolla, Claudia
    Spatti, Gianbattista
    Miceli, Rosalba
    Ferraris, Cristina
    JAMA SURGERY, 2023, 158 (12) : 1275 - 1284
  • [34] Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
    Finch, A.
    Metcalfe, K.
    Lui, J.
    Springate, C.
    Demsky, R.
    Armel, S.
    Rosen, B.
    Murphy, J.
    Elit, L.
    Sun, P.
    Narod, S.
    CLINICAL GENETICS, 2009, 75 (03) : 220 - 224
  • [35] Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
    Powell, C. B.
    Swisher, E. M.
    Cass, I.
    McLennan, J.
    Norquist, B.
    Garcia, R. L.
    Lester, J.
    Karlan, B. Y.
    Chen, L.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 364 - 371
  • [36] Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
    Finch, Amy
    Beiner, Mario
    Lubinski, Jan
    Lynch, Henry T.
    Moller, Pal
    Rosen, Barry
    Murphy, Joan
    Ghadirian, Parviz
    Friedman, Eitan
    Foulkes, William D.
    Kim-Sing, Charmaine
    Wagner, Teresa
    Tung, Nadine
    Couch, Fergus
    Stoppa-Lyonnet, Dominique
    Ainsworth, Peter
    Daly, Mary
    Pasini, Babara
    Gershoni-Baruch, Ruth
    Eng, Charis
    Olopade, Olufunmilayo I.
    McLennan, Jane
    Karlan, Beth
    Weitzel, Jeffrey
    Sun, Ping
    Narod, Steven A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (02): : 185 - 192
  • [37] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726
  • [38] Quality of life in BRCA1 and BRCA2 mutation carriers (B1/2) following risk-reducing salpingo-oophorectomy (RRSO).
    Domchek, Susan M.
    Li, Jiaqi
    Digiovanni, Laura
    Voong, Chan
    Mueller, Rebecca
    Johnson, Lauren
    Epperson, C. Neill
    Friedman, Sue
    Gracia, Clarisa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Estrogens and Cognition in BRCA1/2 Mutation Carriers Following Prophylactic Salpingo-Oophorectomy (Oct, pg 522, 2010)
    Schwartz, Deborah
    Finch, Amy
    Tierney, Mary
    Hampson, Elizabeth
    Narod, Steven
    Einstein, Gillian
    GENDER MEDICINE, 2011, 8 (01) : 56 - 56
  • [40] Does precursor lesion of fallopian tube carcinoma exist in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers? A preliminary study
    Royal, Virginie
    Penault-Llorca, Frederique
    Abaji, Christine
    Lussier, Christian
    Benayoun, Serge
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Tonin, Patricia
    Maugard, Christine
    MODERN PATHOLOGY, 2006, 19 : 103 - 103
12345